- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04294212
Medical Termination of Pregnancy : Evaluation of Patients' Practices and Feelings in Brest Hospital (IMGEPR)
March 2, 2020 updated by: University Hospital, Brest
This study evaluate the feelings of patients about a medical termination of pregnancy that they experienced in Brest Hospital.
Patients responded to an online questionnaire assessing their feelings at each stage of the medical termination process.
Their answers were associated with their medical data.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Brest, France, 29609
- Recruiting
- CHRU de Brest
-
Contact:
- Anne-Hélène saliou
- Phone Number: 02-98-22-35-33
- Email: anne-helene.saliou@chu-brest.fr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
all patients having experienced a medical termination of pregnancy in Brest Hospital
Description
Inclusion Criteria:
- Patient having experienced a medical termination of pregnancy in Brest Hospital
- Medical termination of pregnancy after 14 weeks
- Induction for natural delivery
- No opposition
Exclusion Criteria:
- Medical termination of pregnancy before 14 weeks
- Selective termination of pregnancy (multiple pregnancy)
- Caesarean
- Patient not speaking french
- Patient's refusal
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall satisfaction score
Time Frame: One day
|
answers to a satisfaction questionnaire based on a numerical scale ranging from 0 (dissatisfaction) to 3 (satisfaction), then calculation of the overall score
|
One day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
satisfaction score by indicator
Time Frame: One day
|
satisfaction questionnaire divided into several parts according to an indicator
|
One day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 10, 2020
Primary Completion (ANTICIPATED)
August 10, 2020
Study Completion (ANTICIPATED)
August 10, 2020
Study Registration Dates
First Submitted
March 2, 2020
First Submitted That Met QC Criteria
March 2, 2020
First Posted (ACTUAL)
March 4, 2020
Study Record Updates
Last Update Posted (ACTUAL)
March 4, 2020
Last Update Submitted That Met QC Criteria
March 2, 2020
Last Verified
March 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- IMGEPR (29BRC19.0245)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All collected data that underlie results in a publication
IPD Sharing Time Frame
Data will be available beginning two year and ending five years following the publication
IPD Sharing Access Criteria
Data access requests will be reviewed by the internal committee of Brest UH.
Requestors will be required to sign and complete a data access agreement
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Medical Termination of Pregnancy
-
Centre Hospitalier Universitaire DijonRecruitingMedical Termination of Pregnancy | Voluntary Termination of PregnancyFrance
-
Hospices Civils de LyonCompletedMedical Termination of PregnancyFrance
-
Centre Hospitalier de Saint-DenisActive, not recruitingPregnancy | Termination of Pregnancy | Violence | Abortion | Medical Abortion | Violence Against Women (VAW) | Voluntary Termination of PregnancyFrance
-
Karolinska InstitutetCompletedMedical Abortion | Early Pregnancy Termination | Postabortion ContraceptionSweden, United Kingdom
-
Nordic Pharma SASCompletedMedical Termination of PregnancyFrance
-
Dr Mudassar Saeed PansotaCompletedTermination of PregnancyPakistan
-
University Hospital, MontpellierCompletedTermination of PregnancyFrance
-
Gynuity Health ProjectsCompletedTermination of PregnancyUnited States
-
Gynuity Health ProjectsCompletedTermination of PregnancyUnited States, Moldova, Republic of, Nepal
-
Oshri BarellUnknownInduced Abortion and Complications of Termination of PregnancyIsrael